Zydus receives USFDA tentative approval Valbenazine Capsules
NEW DELHI: Zydus Lifesciences today said it has got tentative approval from the US health regulator to market its generic...
Zydus
Zydus starts phase IV trial for Desidustat
NEW DELHI: Zydus Lifesciences Ltd. (formerly known as Cadila Healthcare Ltd.), a discovery-driven, global life sciences company announced the commencement...
Zydus receives USFDA’s final approval for Lacosamide injection
NEW DELHI: Ahmedabad-based Zydus Lifesciences Limited said that it has received the final approval from the United States Food and...
Zydus receives final approval from USFDA for Bortezomib for Injection
NEW DELHI: Zydus Lifesciences Ltd has announced that it has received final approval from the United States Food and Drug...
Zydus receives final approval from USFDA for Dapagliflozin Tablets
NEW DELHI: Zydus said that it has received final approval from the USFDA to market Dapagliflozin Tablets in the strengths...
Zydus receives final approval from USFDA for Vigabatrin Tablets
NEW DELHI: Zydus has received final approval from the USFDA to market Vigabatrin Tablets in the strength of 500 mg...
DCGI nod to Phase III trials of two-dose Zydus Covid-19 vaccine
NEW DELHI: The Drugs Controller General of India (DCGI) has permitted Zydus Cadila to conduct Phase III trials of ZyCoV-D,...
Covid-19 vaccine: Zydus applies to the DCGI for EUA to launch ZyCoV-D
NEW DELHI: Zydus Cadila today announced that the company has applied for Emergency Use Authorization (EUA) to the office of...
Zydus seeks DCGI approval for clinical trial of monoclonal antibodies cocktail
NEW DELHI: SARS-CoV-2 spike protein targeted, neutralizing monoclonal antibody based treatments have received emergency use authorization in mild COVID cases...
Covid-19 infection in adults: Zydus receives emergency use approval from DCGI
NEW DELHI: Zydus Cadila today announced that the company has received Restricted Emergency Use Approval from the Drug Controller General...
